181 related articles for article (PubMed ID: 34057377)
41. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
42. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
43. CIC-DUX4 sarcoma diagnosed by fine-needle aspiration cytology: A case report.
Tang S; Dodd LG
Diagn Cytopathol; 2018 Nov; 46(11):958-963. PubMed ID: 30353686
[TBL] [Abstract][Full Text] [Related]
44. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
45. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation.
Panagopoulos I; Thorsen J; Gorunova L; Haugom L; Bjerkehagen B; Davidson B; Heim S; Micci F
Genes Chromosomes Cancer; 2013 Jul; 52(7):610-8. PubMed ID: 23580382
[TBL] [Abstract][Full Text] [Related]
46. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F
Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
48. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
[TBL] [Abstract][Full Text] [Related]
50. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
[TBL] [Abstract][Full Text] [Related]
52. Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.
Yoshida A; Arai Y; Hama N; Chikuta H; Bando Y; Nakano S; Kobayashi E; Shibahara J; Fukuhara H; Komiyama M; Watanabe SI; Tamura K; Kawai A; Shibata T
Histopathology; 2020 Mar; 76(4):509-520. PubMed ID: 31647130
[TBL] [Abstract][Full Text] [Related]
53. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
[TBL] [Abstract][Full Text] [Related]
54. BCOR-CCNB3 Undifferentiated Sarcoma-Does Immunohistochemistry Help in the Identification?
Ludwig K; Alaggio R; Zin A; Peron M; Guzzardo V; Benini S; Righi A; Gambarotti M
Pediatr Dev Pathol; 2017; 20(4):321-329. PubMed ID: 28420319
[TBL] [Abstract][Full Text] [Related]
55. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
[TBL] [Abstract][Full Text] [Related]
56. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.
Graham C; Chilton-MacNeill S; Zielenska M; Somers GR
Hum Pathol; 2012 Feb; 43(2):180-9. PubMed ID: 21813156
[TBL] [Abstract][Full Text] [Related]
57. A Case Series of BCOR Sarcomas With a New Splice Variant of
Kyriazoglou A; Tourkantoni N; Liontos M; Zagouri F; Mahaira L; Papakosta A; Michali D; Patereli A; Stefanaki K; Tzotzola V; Skoura E; Baka M; Polychronopoulou S; Kattamis A; Dimitriadis E
In Vivo; 2020; 34(5):2947-2954. PubMed ID: 32871837
[TBL] [Abstract][Full Text] [Related]
58. BCOR-CCNB3 rearranged sarcoma arising in neck misdiagnosed as thyroid cancer: A case report.
Tan LC; Yu PC; Wang J; Zhou XY; Ji QH; Wang YL
Oral Oncol; 2021 Sep; 120():105290. PubMed ID: 33888406
[TBL] [Abstract][Full Text] [Related]
59. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
60. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
